Look out for symptoms like muscle weakness, mood swings, easy bruising, or slow wound healing
AOD 9604 $52.79
Clinical trial data from the SURMOUNT series shows these incidence rates: Nausea: approximately 20 percent of patients Diarrhea: approximately 16 percent of patients Vomiting: approximately 9 percent of patients Constipation: varies by dose level Decreased appetite: expected therapeutic effect Abdominal pain: less common but reported Most gastrointestinal side effects are mild to moderate and occur during the first few weeks of treatment or after dose increases
However, breaks often result in weight regain, making maintenance dosing or continuous therapy more practical for long-term weight stability
However, it is important to recognise that delayed gastric emptying a known pharmacological effect of Mounjaromay have implications for certain procedures, particularly those requiring sedation or general anaesthesia
Effectiveness for Weight Loss Phentermine: Average weight loss is around 510% of body weight GLP-1 medications: Can lead to 1020% (or more) weight loss in many patients GLP-1s generally produce more significant and sustained results
.webp)
